Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Warning Letter Roundup & Recap – 18 August 2020

Executive Summary

Four enforcement letters were sent by the US FDA to makers of adulterated COVID-19 tests.

You may also be interested in...



COVID-19: FDA Schedules More Virtual Town Halls For November And December

The US agency has announced four more webinars aimed at labs and manufacturers that are (or have) developed diagnostic tests for the novel coronavirus.

Ventilators, Infusion Pumps, PPE, And More: 96 Devices Make FDA’s Critical Medical Products List

The US FDA’s list of essential products for use during infectious diseases outbreaks and other public health threats comes almost three months after President Trump signed an executive order directing the agency to develop one.

FDA Bumps PMA Compliance Date For AED Accessories To February 2022

The US agency is giving manufacturers of automated external defibrillator accessories roughly 15 more months to comply with a 2015 final order that requires them to file premarket submissions with the agency.

Topics

UsernamePublicRestriction

Register

MT142578

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel